Shenzhen, Guangdong, China TriWise Capital appeared to be the VC, which was created in 2015. The company was established in Asia in China. The main office of represented VC is situated in the Shenzhen.
The fund was created by Dajie Tang.
The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the TriWise Capital, startups are often financed by Shenzhen Capital Group, ShenZhen GTJA Investment Group, Qianhai Xino. The meaningful sponsors for the fund in investment in the same round are Shenzhen Capital Group, ShenZhen GTJA Investment Group, Qianhai Fund of Funds. In the next rounds fund is usually obtained by Sino Biopharmaceutical, Shenzhen Capital Group, Loyal Valley Capital.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline Akeso Biopharma Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Related Funds
| Fund Name | Location |
| Alchemy Partners | England, London, United Kingdom |
| CBC Co | - |
| Finn Capital Partners | California, San Francisco, United States |
| Frontier Digital Ventures | Kuala Lumpur, Malaysia |
| Hermes Private Equity | England, London, United Kingdom |
| ING Furman Selz Asset Management | New York, New York, United States |
| Jinggong Hongyuan | Beijing, Beijing, China |
| Kentucky Cabinet For Economic Development | - |
| NeoCarta Ventures | California, San Mateo, United States |
| Newton Fund | California, San Francisco, United States |
| Nomow Incubator | Ar Riyad, Riyadh, Saudi Arabia |
| Onroad Capital | China, Guangdong, Shenzhen |
| Rainmakers | California, San Francisco, United States |
| Rebel Foods | India, Maharashtra, Pune |
| Renault | Boulogne-Billancourt, France, Ile-de-France |
| RSVP Capital | Ann Arbor, Michigan, United States |
| Space Capital | New York, New York, United States |
| Swisscom | Bern, Switzerland, Worblaufen |
| Trust China | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shentuo Biotechnology | 29 Dec 2023 | Wuxi Shi, Jiangsu, China | |||
Heranova Lifesciences | $3M | 28 Dec 2023 | Huangpu, Shanghai, China | ||
Hengsai Biological | $15M | 27 Nov 2023 | - | ||
Conmind Medical | $15M | 21 Aug 2023 | Shenzhen, Guangdong, China | ||
Bite Micro | 21 Jun 2023 | Shenzhen, Guangdong, China | |||
Immune-Onc Therapeutics | $25M | 05 Jan 2023 | Palo Alto, California, United States | ||
Qyuns Therapeutics | $15M | 07 Mar 2022 | Taizhou, Jiangsu, China | ||
Innoforce Pharmaceuticals | $57M | 06 Dec 2021 | Hangzhou, Zhejiang, China | ||
Triastek | 23 Nov 2021 | Nanjing, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shentuo Biotechnology | 29 Dec 2023 | Wuxi Shi, Jiangsu, China | |||
Heranova Lifesciences | $3M | 28 Dec 2023 | Huangpu, Shanghai, China | ||
Hengsai Biological | $15M | 27 Nov 2023 | - | ||
Conmind Medical | $15M | 21 Aug 2023 | Shenzhen, Guangdong, China | ||
Bite Micro | 21 Jun 2023 | Shenzhen, Guangdong, China | |||
Immune-Onc Therapeutics | $25M | 05 Jan 2023 | Palo Alto, California, United States | ||
Qyuns Therapeutics | $15M | 07 Mar 2022 | Taizhou, Jiangsu, China | ||
Innoforce Pharmaceuticals | $57M | 06 Dec 2021 | Hangzhou, Zhejiang, China | ||
Triastek | 23 Nov 2021 | Nanjing, Jiangsu, China |
